Healthcare provider profile · identity verified

Michele B Raglin, MD

Internal Medicine · CORPUS CHRISTI, TX · NPI 1326084211

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1191	449
Losartan Potassium	Losartan Potassium	609	223
Levothyroxine Sodium	Levothyroxine Sodium	575	213
Amlodipine Besylate	Amlodipine Besylate	527	201
Lisinopril	Lisinopril	526	204
Metformin Hcl	Metformin Hcl	433	172
Metoprolol Succinate	Metoprolol Succinate	379	120
Pantoprazole Sodium	Pantoprazole Sodium	378	145
Rosuvastatin Calcium	Rosuvastatin Calcium	278	113
Pravastatin Sodium	Pravastatin Sodium	265	95
Gabapentin	Gabapentin	239	106
Simvastatin	Simvastatin	234	77
Omeprazole	Omeprazole	223	91
Furosemide	Furosemide	213	82
Hydrochlorothiazide	Hydrochlorothiazide	205	89
Albuterol Sulfate Hfa	Albuterol Sulfate	174	66
Jardiance	Empagliflozin	143	46
Metoprolol Tartrate	Metoprolol Tartrate	131	47
Tamsulosin Hcl	Tamsulosin Hcl	128	56
Fluticasone Propionate	Fluticasone Propionate	127	46
Clopidogrel	Clopidogrel Bisulfate	122	51
Montelukast Sodium	Montelukast Sodium	120	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	113	34
Glimepiride	Glimepiride	111	48
Duloxetine Hcl	Duloxetine Hcl	106	39
Trazodone Hcl	Trazodone Hcl	102	51
Famotidine	Famotidine	100	48
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	91	37
Sertraline Hcl	Sertraline Hcl	88	38
Trulicity	Dulaglutide	85	36
Ozempic	Semaglutide	80	33
Eliquis	Apixaban	78	26
Symbicort	Budesonide/Formoterol Fumarate	74	22
Metformin Hcl Er	Metformin Hcl	71	30
Alendronate Sodium	Alendronate Sodium	68	26
Glipizide	Glipizide	68	32
Bupropion Xl	Bupropion Hcl	67	24
Mounjaro	Tirzepatide	66	23
Spironolactone	Spironolactone	63	20
Escitalopram Oxalate	Escitalopram Oxalate	62	27
Potassium Chloride	Potassium Chloride	62	31
Buspirone Hcl	Buspirone Hcl	61	29
Meloxicam	Meloxicam	59	27
Fluoxetine Hcl	Fluoxetine Hcl	58	17
Hydralazine Hcl	Hydralazine Hcl	58	27
Tizanidine Hcl	Tizanidine Hcl	58	36
Tramadol Hcl	Tramadol Hcl	58	33
Valsartan	Valsartan	57	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	17
Citalopram Hbr	Citalopram Hydrobromide	53	25
Carvedilol	Carvedilol	51	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	19
Allopurinol	Allopurinol	49	20
Januvia	Sitagliptin Phosphate	47	15
Olmesartan Medoxomil	Olmesartan Medoxomil	45	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	16
Finasteride	Finasteride	43	18
Ezetimibe	Ezetimibe	42	14
Bydureon Bcise	Exenatide Microspheres	40	13
Pioglitazone Hcl	Pioglitazone Hcl	40	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	15
Fenofibrate	Fenofibrate	38	13
Azithromycin	Azithromycin	37	36
Myrbetriq	Mirabegron	37	15
Oxybutynin Chloride	Oxybutynin Chloride	37	12
Donepezil Hcl	Donepezil Hcl	34	13
Tradjenta	Linagliptin	34	12
Acetaminophen-Codeine	Acetaminophen With Codeine	32	16
Quetiapine Fumarate	Quetiapine Fumarate	32	12
Ibuprofen	Ibuprofen	31	20
Synthroid	Levothyroxine Sodium	31	suppressed
Nifedipine Er	Nifedipine	30	11
Irbesartan	Irbesartan	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	25
Memantine Hcl	Memantine Hcl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	25
Ondansetron Hcl	Ondansetron Hcl	27	18
Benazepril Hcl	Benazepril Hcl	26	12
Lovastatin	Lovastatin	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	24
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	11
Naproxen	Naproxen	24	14
Incontrol Pen Needle	Pen Needle, Diabetic	23	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	12
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	22
Folic Acid	Folic Acid	22	suppressed
Mirtazapine	Mirtazapine	22	13
Oxybutynin Chloride Er	Oxybutynin Chloride	22	12
Vitamin D2	Ergocalciferol (Vitamin D2)	22	suppressed
Ramipril	Ramipril	20	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Atenolol	Atenolol	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	12
Methylprednisolone	Methylprednisolone	19	19
Alprazolam	Alprazolam	18	15
Baclofen	Baclofen	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	14
Glipizide Er	Glipizide	18	suppressed
Prednisone	Prednisone	18	15
Clonazepam	Clonazepam	17	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Ondansetron Odt	Ondansetron	15	14
Pregabalin	Pregabalin	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	13
Celecoxib	Celecoxib	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Constulose	Lactulose	13	suppressed
Linzess	Linaclotide	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Topiramate	Topiramate	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Tivicay	Dolutegravir Sodium	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error